Absci Investor Presentation Deck

De novo design in silico De novo drug creation with 'zero- shot' generative Al Target antigen structure US De novo antibody designs YY YYYYYY Y YYYY YYYYYY ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Target epitope Wet lab assays ACE assay data Antibody scaffold sequence SPR assay data ai. Validated de novo binders ی و دیگری دارد که m absci. 12

View entire presentation